Prevalence of mental health disorders in inflammatory bowel disease: An Australian outpatient cohort

Clinical and Experimental Gastroenterology

Volumn 8, Issue , 2015, Pages 197-204

  Tribbick, Davina ^a   Salzberg, Michael ^b,c   Ftanou, Maria ^b,d   Connell, William R ^b   Macrae, Finlay ^c,e   Kamm, Michael A ^b,e,f   Bates, Glen W ^a   Cunningham, Georgina ^b   Austin, David W ^g   Knowles, Simon R ^a,b,c,e  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g DEAKIN UNIVERSITY   (Australia)

Author keywords

Disease activity; Inflammatory bowel disease; Psychological conditions

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; AUSTRALIAN; COHORT ANALYSIS; CROHN DISEASE; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSESSMENT; DISEASE SEVERITY; DYSTHYMIA; FEMALE; GENERALIZED ANXIETY DISORDER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH SERVICE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT; PANIC; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; QUESTIONNAIRE; SOCIAL PHOBIA; TERTIARY CARE CENTER; ULCERATIVE COLITIS;

EID: 84938413428     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S77567     Document Type: Article

References (42)

1. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009;15(7):1105-1118.
2. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis. 2007;13(2):225-234.
3. Porcelli P, Zaka S, Centonze S, Sisto G. Psychological distress and levels of disease activity in inflammatory bowel disease. Ital J Gastroenterol. 1994;26(3):111-115.
4. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004;66(1):79-84.
5. Moser G. Should we incorporate psychological care into the management of IBD? Nat Clin Pract Gastroenterol Hepatol. 2006;3(8): 416-417.
6. Mardini HE, Kip KE, Wilson JW. Crohn’s disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci. 2004;49(3):492-497.
7. Persoons P, Vermeire S, Demyttenaere K, et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment Pharmacol Ther. 2005;22(2): 101-110.
8. Bennebroek Evertsz F, Thijssens NAM, Stokkers PC, et al. Do Inflammatory Bowel Disease patients with anxiety and depressive symptoms receive the care they need? J Crohns Colitis. 2012;6(1):68-76.
9. Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. Am J Gastroenterol. 2002;97(8):1994-1999.
10. Knowles SR, Wilson JL, Connell WR, Kamm MA. Preliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn’s disease guided by the common sense model of illness. Inflamm Bowel Dis. 2011;17(12):2551-2557.
11. Wilson J, Hair C, Knight R, et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis. 2010;16(9):1550-1556.
12. Miehsler W, Weichselberger M, Öfferlbauer-Ernst A, et al. Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis. 2008;14(9):1273-1280.
13. Mikocka-Walus AA, Turnbull DA, Andrews JM, et al. Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. Clin Pract Epidemiol Men Health. 2008;4:15.
14. Nordin K, Pahlman L, Larsson K, Sundberg-Hjelm M, Loof L. Healthrelated quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37(4):450-457.
15. Robertson DA, Ray J, Diamond I, Edwards JG. Personality profile and affective state of patients with inflammatory bowel disease. Gut. 1989;30(5):623-626.
16. Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97(2):389-396.
17. Lima FD, Ribeiro TC, Chebli LA, et al. Mood swings in patients with Crohn’s disease: incidence and associated factors. Rev Assoc Med Bras. 2012;58(4):481-488.
18. Meder A, Świątkowski M, Meder G, Koza J. Quality of life and coexisting anxiety-depressive disorders in patients with inflammatory bowel disease during relapse and a further 11 months observation. Polish Gastroenterology. 2010;17(4):273-279.
19. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut. 1987;28(12):1600-1604.
20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.
21. Helzer JE, Stillings WA, Chammas S, Norland CC, Alpers DH. A controlled study of the association between ulcerative colitis and psychiatric diagnoses. Dig Dis Sci. 1982;27(6):513-518.
22. Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med. 1995;25(6):1259-1267.
23. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103(8): 1989-1997.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. 3rd ed. Washington, DC: American Psychiatric Association; 1987.
25. Robins LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069-1077.
26. Wittchen HU. Reliability and validity studies of the WHO - Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28(1):57-84.
27. American Psychiatric Association. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000.
28. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006;12(8):697-707.
29. Clara I, Lix LM, Walker JR, et al. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol. 2009;104(7):1754-1763.
30. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77.
31. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33; quiz 34-57.
32. Noyes K, Liu H, Lyness JM, Friedman B. Medicare beneficiaries with depression: comparing diagnoses in claims data with the results of screening. Psychiatr Serv. 2011;62(10):1159-1166.
33. Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105(9):1994-2002.
34. Graff LA, Walker JR, Clara I, et al. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol. 2009;104(12):2959-2969.
35. Rawsthorne P, Clara I, Graff LA, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products. Gut. 2012;61(4):521-527.
36. Singh S, Blanchard A, Walker JR, Graff LA, Miller N, Bernstein CN. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2011;9(9):769-775.
37. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
38. Oakley Browne MA, Wells JE, Scott KM, editors. Te Rau Hinengaro: The New Zealand Mental Health Survey. Wellington: Ministry of Health; 2006.
39. van Langenberg DR, Lange K, Hetzel DJ, Holtmann GJ, Andrews JM. Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change. J Gastroenterol Hepatol. 2010;25(7):1250-1258.
40. Addolorato G, Capristo E, Stefanini G, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol. 1997;32(10):1013-1021.
41. Agostini A, Moretti M, Calabrese C, et al. Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis. 2014;29(10):1291-1296.
42. Agostini A, Rizzello F, Ravegnani G, et al. Parental bonding and inflammatory bowel disease. Psychosomatics. 2010;51(1):14-21.